TODD NATHAN: Open Payments
NPI 1861734428 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 25 payments from 5 companies in 2025. Trend: 2023 $116 · 2024 $519 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $260 |
| Otsuka America Pharmaceutical, Inc. | 5 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $134 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Alkermes, Inc. | 2 | $45 |
Products named: UZEDY, ABILIFY ASIMTUFII, CAPLYTA, COBENFY, ARISTADA.
Industry payments across CA — which companies pay providers there.
